Inor Medical Products Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 28-07-2024
- Paid Up Capital ₹ 4.80 M
as on 28-07-2024
- Company Age 51 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.65 Cr
as on 28-07-2024
- Satisfied Charges ₹ 2.25 Cr
as on 28-07-2024
- Revenue -47.30%
(FY 2023)
- Profit 8.27%
(FY 2023)
- Ebitda 82.57%
(FY 2023)
- Net Worth -11.88%
(FY 2023)
- Total Assets -1.38%
(FY 2023)
About Inor Medical Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.80 M.
The company currently has active open charges totaling ₹1.65 Cr. The company has closed loans amounting to ₹2.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nitin Datanwala, Lalita Rajesh, Murli Purohit, and One other member serve as directors at the Company.
- CIN/LLPIN
U51100MH1972PLC016213
- Company No.
016213
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1972
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Inor Medical Products?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Datanwala  | Director | 14-Mar-2007 | Current |
| Lalita Rajesh | Additional Director | 25-Apr-2024 | Current |
| Murli Purohit | Additional Director | 25-Apr-2024 | Current |
| Alok Sureka | Additional Director | 25-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Inor Medical Products.
Inor Medical Products Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.3% decrease. The company also saw a slight improvement in profitability, with a 8.27% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inor Medical Products?
In 2023, Inor Medical Products had a promoter holding of 100.00%. The company had 1 Subsidiary and 8 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dpi Products And Services LimitedActive 62 years 7 monthsLalita Rajesh, Murli Purohit and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Banking Corpn Ltd Creation Date: 19 Dec 1997 | ₹1.10 Cr | Open |
Corporation Bank Creation Date: 20 Jul 1993 | ₹1.50 M | Open |
The British Bank Of Middle East Creation Date: 21 Jul 1987 | ₹2.00 M | Open |
How Many Employees Work at Inor Medical Products?
Unlock and access historical data on people associated with Inor Medical Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inor Medical Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inor Medical Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
